return2ozma@lemmy.world to Uplifting News@lemmy.worldEnglish · 22 days agoFDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new optionwww.cnbc.comexternal-linkmessage-square6fedilinkarrow-up189arrow-down11
arrow-up188arrow-down1external-linkFDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new optionwww.cnbc.comreturn2ozma@lemmy.world to Uplifting News@lemmy.worldEnglish · 22 days agomessage-square6fedilink
minus-squareShoeThrower@lemmy.ziplinkfedilinkEnglisharrow-up4·22 days agoIn the US it will cost $30,000 per year of treatment, while a generic version could be sold for $40 and still be massively profitable.
In the US it will cost $30,000 per year of treatment, while a generic version could be sold for $40 and still be massively profitable.